Attention HEALTHCARE & LIFE SCIENCES sector professionals . What are the promising sectors driving m&a activity for lower mid market investment banks?

Hello, I have a case study presentation to select a few sub sectors within the healthcare and life sciences space and present on the commercial opportunity about the sub sector and also specific companies I can suggest for this IB to go after. Looking for companies with revenues of £5m - £35m as it is a lower mid market IB. I have been told look at sub sectors that have not had much activity in the last 3 years or are still fragmented sectors essentially where the promise could be for growth in those sectors. If you have any ideas would be much appreciated. I have been told don’t look at hospitals or nursing homes and have been given ideas like medical device cdmo’s and niche cro’s healthcare data analytics. Any ideas on other sub sectors please I should consider? Also any suggested readings would be really helpful. The focus should be UK/ Europe but happy to consider from a global perspective. Thank you!

4 Comments
 

medical communications

in general, look at CROs and think of what might be good target for them. some mid-market names include bioscript, lucid, helios, prescient

some are body shops where Rev per FTE is pretty much the same but by aggregating into bigger group, you benefit a bit from scale and reputation and expanding into adjacent areas (e.g. covering the whole lifecycle or becoming a one-stop shop) gives you multiple arbitrage. this is one reason why they're being consolidated

 

Hic quia quia in rem ab similique vero. Vero necessitatibus perspiciatis et perferendis quas reprehenderit sapiente. Laborum eaque provident repellat est architecto voluptate. A quia voluptatem ex.

Sit ut corporis molestias sit sed quia praesentium aperiam. Dicta eum eaque est voluptatem esse. Ipsa id nesciunt ipsa. Assumenda reiciendis itaque consequuntur ut aut ab possimus.

Odit aspernatur et maxime est error id. Et facere eum minima. Modi possimus consequatur consectetur sed. Nam itaque natus voluptas suscipit itaque distinctio.

Consequatur sunt ipsum hic rerum. At officia quaerat sunt et facere consequuntur. Ex ut quia esse voluptatem. Porro totam qui dolores vitae quisquam reprehenderit.

Career Advancement Opportunities

September 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

September 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

September 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

September 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (235) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (273) $126
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”